Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 5,063,239 |
|
|||||
| News | - | ||||||
| Day High | 1.63 | Low High |
|||||
| Day Low | 1.40 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aerovate Therapeutics Inc | AVTE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.24 | -14.55% | 1.41 | 23:00:07 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.61 | 1.40 | 1.63 | 1.41 | 1.65 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,153 | 5,063,239 | US$ 1.49 | US$ 7,535,327 | - | 1.40 - 32.415 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:48 | formt | 3,071 | US$ 1.41 | USD |
Aerovate Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 39.01M | 27.67M | - | 0 | -75.52M | -2.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aerovate Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVTE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.72 | 25.285 | 1.40 | 2.67 | 5,264,830 | -20.31 | -93.51% |
| 1 Month | 20.33 | 25.285 | 1.40 | 4.85 | 1,605,023 | -18.92 | -93.06% |
| 3 Months | 26.55 | 32.415 | 1.40 | 8.61 | 653,055 | -25.14 | -94.69% |
| 6 Months | 18.01 | 32.415 | 1.40 | 10.55 | 356,645 | -16.60 | -92.17% |
| 1 Year | 16.54 | 32.415 | 1.40 | 11.33 | 217,172 | -15.13 | -91.48% |
| 3 Years | 28.00 | 32.415 | 1.40 | 14.56 | 138,113 | -26.59 | -94.96% |
| 5 Years | 28.00 | 32.415 | 1.40 | 14.56 | 138,113 | -26.59 | -94.96% |
Aerovate Therapeutics Description
| Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. |
